Grufity logoGrufity logo

Cardlytics Inc Stock Research

CDLX

2.72USD+0.05(+1.87%)Delayedas of 27 Mar 2023, 02:00 pm

Market Summary

USD2.72+0.05
Delayedas of 27 Mar 2023, 02:00 pm
1.87%

CDLX Stock Price

CDLX RSI Chart

CDLX Valuation

Market Cap

88.0M

Price/Earnings (Trailing)

-0.19

Price/Sales (Trailing)

0.29

EV/EBITDA

0.08

Price/Free Cashflow

-1.6

CDLX Price/Sales (Trailing)

CDLX Profitability

EBT Margin

-156.33%

Return on Equity

-219.87%

Return on Assets

-67.31%

Free Cashflow Yield

-62.6%

CDLX Fundamentals

CDLX Revenue

Revenue (TTM)

298.5M

Revenue Y/Y

-8.38%

Revenue Q/Q

13.47%

CDLX Earnings

Earnings (TTM)

-465.3M

Earnings Y/Y

-3.1K%

Earnings Q/Q

-6.1K%

Price Action

52 Week Range

2.5761.83
(Low)(High)

Last 7 days

-20.8%

Last 30 days

-56.7%

Last 90 days

-44.6%

Trailing 12 Months

-95.7%

CDLX Financial Health

Current Ratio

1

Debt/Equity

0.33

Debt/Cashflow

-0.2

CDLX Investor Care

Buy Backs (1Y)

0.46%

Diluted EPS (TTM)

-2.97

Peers (Alternatives to Cardlytics)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
54.3B
54.0B
-10.11% -38.51%
10.75
1.01
4.53% 8.62%
17.8B
14.3B
-4.59% 5.37%
13.49
1.24
0.00% -6.49%
14.7B
9.0B
-14.32% -41.38%
12.09
1.63
3.53% -7.69%
13.5B
10.9B
-4.05% -1.69%
14.44
1.24
6.71% -1.55%
MID-CAP
6.3B
5.2B
-5.92% -2.26%
6.48
1.21
12.10% 16.37%
4.6B
16.7B
-33.10% -71.68%
1.96
0.28
-6.72% -3.38%
SMALL-CAP
1.9B
2.0B
-12.63% 8.83%
210.69
0.94
-10.52% -93.34%
1.0B
297.5M
-8.85% -56.76%
24.71
3.46
12.93% 4284.51%
738.0M
2.5B
-36.42% -70.27%
-5.57
0.29
10.71% 77.73%
595.8M
3.9B
-46.88% -79.34%
-2.25
0.15
9.95% -66.25%
244.0M
325.9M
-5.99% -0.82%
2.45
0.75
123.99% 195.03%
102.2M
376.4M
-5.13% -58.27%
-1.54
0.27
2.56% -33.02%
88.0M
298.5M
-56.73% -95.70%
-0.19
0.29
11.76% -261.89%
40.0M
256.6M
-3.79% -5.93%
-28.86
0.16
0.62% -122.10%
13.9M
38.3M
-12.65% -25.48%
6.77
0.36
112.29% 53.70%

Financials for Cardlytics

Income Statement (Last 12 Months)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue-2.5%298,542,000306,088,000298,366,000281,814,000267,116,000
  S&GA Expenses-2.8%74,745,00076,918,00075,362,00070,442,00065,996,000
  R&D Expenses5.8%54,435,00051,445,00048,824,00044,177,00038,104,000
EBITDA-491.7%-434,819,000-73,490,000-128,992,000-52,284,000-
EBITDA Margin-506.6%-1.46-0.24-0.43-0.19-
Earnings Before Taxes-331.6%-466,710,000-108,130,000-158,926,000-78,496,000-136,429,000
EBT Margin-342.5%-1.56-0.35-0.53-0.28-
Interest Expenses31.6%-5,653,000-8,266,000-10,465,000-12,563,000-
Net Income-370.8%-465,264,000-98,820,000-149,616,000-70,632,000-128,565,000
Net Income Margin-382.7%-1.56-0.32-0.50-0.25-
Free Cahsflow-26.9%-55,075,000-43,411,000-39,589,000-47,810,000-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets-35.2%6911,0661,0901,2311,264
  Current Assets0.4%250249264319359
    Cash Equivalents-11.9%122139157208233
  Net PPE-16.7%6.007.009.0010.0011.00
  Goodwill-47.0%353666666748743
Liabilities-1.3%480486525520573
  Current Liabilities-2.3%249255294247327
  Long Term Debt-184----
Shareholder's Equity-63.5%212581564712691
  Retained Earnings-63.2%-976-598-604-478-522
  Additional Paid-In Capital1.1%1,1831,1691,1631,1881,213
Shares Outstanding-2.5%33.0034.0034.00--
Cashflow (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-30.3%-53.90-41.36-37.38-45.68-38.52
  Share Based Compensation-0.8%45.0045.0056.0057.0050.00
Cashflow From Investing1.6%-15.76-16.02-15.59-359-506
Cashflow From Financing-1.0%-39.99-39.58-39.212.00486
  Buy Backs-25.0%40.0053.0053.000.00-

Risks for CDLX

What is the probability of a big loss on CDLX?

99.2%


Probability that Cardlytics stock will be more than 20% underwater in next one year

79.2%


Probability that Cardlytics stock will be more than 30% underwater in next one year.

77.7%


Probability that Cardlytics stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CDLX drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Cardlytics was unfortunately bought at previous high price.

Drawdowns

Returns for CDLX

Cumulative Returns on CDLX

-30.5%


5-Year Cumulative Returns

-59.3%


3-Year Cumulative Returns

What are the long-term rolling returns for CDLX?

FIve years rolling returns for Cardlytics.

Annualized Returns

Which funds bought or sold CDLX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
BAILLIE GIFFORD & CO
added
30.69
-2,029,650
8,301,350
0.01%
2023-02-28
Voya Investment Management LLC
unchanged
-
-45,999
73,001
-%
2023-02-22
CVA Family Office, LLC
unchanged
-
-2,110
2,890
-%
2023-02-21
MACQUARIE GROUP LTD
sold off
-100
-4,000
-
-%
2023-02-15
NOMURA HOLDINGS INC
unchanged
-
-203,000
324,000
-%
2023-02-15
MetLife Investment Management, LLC
unchanged
-
-62,966
101,034
-%
2023-02-15
GAMCO INVESTORS, INC. ET AL
sold off
-100
-152,000
-
-%
2023-02-15
PERSONAL CAPITAL ADVISORS CORP
unchanged
-
-142,297
227,703
-%
2023-02-15
ALLIANCEBERNSTEIN L.P.
added
66.56
7,854
313,854
-%
2023-02-15
JANE STREET GROUP, LLC
new
-
313,322
313,322
-%

1–10 of 41

Latest Funds Activity

Are funds buying CDLX calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own CDLX
No. of Funds

Cardlytics News

The News Heater

Cardlytics Inc. (CDLX) Shares Down Despite Recent Market Volatility.

The News Heater,
5 hours ago

Marketscreener.com

Cardlytics Announces CFO Transition.

Marketscreener.com,
4 days ago

InvestorsObserver

InvestorsObserver

Beaumont Enterprise

Cardlytics: Q4 Earnings Snapshot.

Beaumont Enterprise,
26 days ago

Schedule 13G FIlings of Cardlytics

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 15, 2023
683 capital management, llc
5.7%
1,883,020
SC 13G/A
Feb 14, 2023
cas investment partners, llc
16.3%
5,416,116
SC 13G/A
Feb 09, 2023
vanguard group inc
7.21%
2,392,757
SC 13G/A
Feb 07, 2023
blackrock inc.
8.2%
2,724,485
SC 13G/A
Sep 09, 2022
wellington management group llp
5.93%
1,951,407
SC 13G/A
Jul 21, 2022
683 capital management, llc
6.4%
2,176,659
SC 13G
Jun 03, 2022
jpmorgan chase & co
0.4%
153,697
SC 13G/A
Feb 14, 2022
cas investment partners, llc
15.6%
5,186,466
SC 13G/A
Feb 09, 2022
vanguard group inc
8.73%
2,905,042
SC 13G/A
Feb 04, 2022
wellington management group llp
11.58%
3,854,015
SC 13G/A

CDLX Fair Value

Cardlytics fair value in different scenarios

The table shows the Fair Value estimates for Cardlytics for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

-

-

-

-

-

-

-

-

-

-
Current Inflation

4.76

75.00%

5.66

108.09%

7.74

184.56%

10.32

279.41%

12.84

372.06%
Very High Inflation

-

-

-

-

-

-

-

-

-

-

Historical Cardlytics Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Cardlytics

View All Filings
Date Filed Form Type Document
Mar 22, 2023
8-K
Current Report
Mar 14, 2023
8-K
Current Report
Mar 01, 2023
POSASR
POSASR
Mar 01, 2023
POS AM
POS AM
Mar 01, 2023
8-K
Current Report
Mar 01, 2023
10-K
Annual Report
Feb 15, 2023
SC 13G/A
Major Ownership Report
Feb 14, 2023
SC 13G/A
Major Ownership Report
Feb 09, 2023
SC 13G/A
Major Ownership Report
Feb 07, 2023
SC 13G/A
Major Ownership Report

Latest Insider Trading transactions for CDLX

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-01-12
Christiansen Andrew
acquired
-
-
8,137
chief financial officer
2023-01-12
Lynton Nicholas Hollmeyer
acquired
-
-
6,312
chief legal & privacy officer
2022-12-09
Lynton Nicholas Hollmeyer
acquired
-
-
1,250
chief legal & privacy officer
2022-12-09
Christiansen Andrew
acquired
-
-
1,875
chief financial officer
2022-11-09
BALEN JOHN V
bought
11,398
3.7995
3,000
-
2022-11-08
Grimes Scott D.
sold
-23.52
3.92
-6.00
-
2022-11-08
Christiansen Andrew
sold
-271
3.995
-68.00
chief financial officer
2022-11-08
Lynton Nicholas Hollmeyer
sold
-3.92
3.92
-1.00
chief legal & privacy officer
2022-11-08
BALEN JOHN V
bought
23,698
3.9497
6,000
-
2022-11-08
Grimes Scott D.
sold
-1,968
3.985
-494
-

1–10 of 50

Lynne M. Laube
590
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

CDLX Income Statement

2022-12-31
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]   
Revenue$ 298,542$ 267,116$ 186,892
Costs and expenses:   
Partner Share and other third-party costs155,507141,273109,308
Delivery costs30,40322,50314,310
Sales and marketing expense74,74565,99645,307
Research and development expense54,43538,10417,532
General and administration expense81,44666,22246,532
Acquisition and integration costs (benefits)(2,874)24,3720
Change in fair value of contingent consideration(128,174)1,3740
Impairment of goodwill and intangible assets453,28800
Depreciation and amortization expense37,54429,8717,826
Total costs and expenses756,320389,715240,815
Operating loss(457,778)(122,599)(53,923)
Other Income and Expenses [Abstract]   
Interest expense, net(2,556)(12,563)(3,048)
Other Nonoperating Income (Expense)(6,376)(1,267)1,549
Nonoperating Income (Expense), Total(8,932)(13,830)(1,499)
Loss before income taxes(466,710)(136,429)(55,422)
Income tax benefit1,4467,8640
Net loss(465,264)(128,565)(55,422)
Net loss attributable to common stockholders$ (465,264)$ (128,565)$ (55,422)
Earnings Per Share, Basic$ (13.92)$ (3.99)$ (2.04)
Weighted-average common shares outstanding, basic (in shares)33,41932,20227,213

CDLX Balance Sheet

2022-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 121,905$ 233,467
Restricted cash8095
Accounts receivable and contract assets, net115,609111,085
Other receivables4,4706,097
Prepaid expenses and other assets7,9787,981
Total current assets250,042358,725
Long-term assets:  
Property and equipment, net5,91611,273
Right-of-use assets under operating leases, net6,57110,196
Intangible assets, net53,475125,550
Goodwill352,721742,516
Capitalized software development costs, net19,92513,131
Deferred implementation costs, net00
Other long-term assets, net2,5862,406
Total assets691,2361,263,797
Current liabilities:  
Accounts payable3,7654,619
Accrued liabilities:  
Accrued compensation10,48612,136
Accrued expenses21,33519,620
Partner Share liability48,59346,595
Consumer Incentive liability53,98352,602
Deferred revenue1,7513,280
Current operating lease liabilities4,9106,028
contingent consideration liability, current(104,121)(182,470)
Total current liabilities248,944327,350
Convertible Debt, Noncurrent226,047184,398
Long-term liabilities:  
Contract with Customer, Liability, Noncurrent334173
Long-term operating lease liabilities4,3066,801
contingent consideration liability, long term0(49,825)
Other long-term liabilities04,550
Liabilities479,631573,097
Stockholders’ equity:  
Common stock, $0.0001 par value—100,000 shares authorized and 33,534 and 33,477 shares issued and outstanding as of December 31, 2021 and December 31, 2022, respectively99
Additional paid-in capital1,182,5681,212,823
Accumulated other comprehensive income5,598486
Accumulated deficit(976,570)(522,618)
Total stockholders’ equity211,605690,700
Total liabilities and stockholders’ equity$ 691,236$ 1,263,797